If that's the case then IMU really should stop the clinical trial right away and announce this to the ASX. Given the patient was only on the clinical trial for 2 months compared to the others, this is an abnormal data point to me, just like @fourdollars state the one patient who has been on the clinical trial the longest and achieved CR was an "abnormal" data point. But you as a share holder should decide for yourself.
Media Thread, page-13573
-
- There are more pages in this discussion • 1,096 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $418.9M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 11337 | 8.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.5¢ | 100000 | 1 |
View Market Depth
| Last trade - 10.01am 16/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
Day chart unavailable